Literature DB >> 33322016

Difficult and Severe Asthma in Children.

Federica Porcaro1, Nicola Ullmann1, Annalisa Allegorico1, Antonio Di Marco1, Renato Cutrera1.   

Abstract

Asthma is the most frequent chronic inflammatory disease of the lower airways affecting children, and it can still be considered a challenge for pediatricians. Although most asthmatic patients are symptom-free with standard treatments, a small percentage of them suffer from uncontrolled persistent asthma. In these children, a multidisciplinary systematic assessment, including comorbidities, treatment-related issues, environmental exposures, and psychosocial factors is needed. The identification of modifiable factors is important to differentiate children with difficult asthma from those with true severe therapy-resistant asthma. Early intervention on modifiable factors for children with difficult asthma allows for better control of asthma without the need for invasive investigation and further escalation of treatment. Otherwise, addressing a correct diagnosis of true severe therapy-resistant asthma avoids diagnostic and therapeutic delays, allowing patients to benefit from using new and advanced biological therapies.

Entities:  

Keywords:  asthma; biologic drugs; children; difficult asthma; severe asthma

Year:  2020        PMID: 33322016      PMCID: PMC7764801          DOI: 10.3390/children7120286

Source DB:  PubMed          Journal:  Children (Basel)        ISSN: 2227-9067


  88 in total

1.  Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype.

Authors:  Atul Gupta; Masanori Ikeda; Bob Geng; Jay Azmi; Robert G Price; Eric S Bradford; Steven W Yancey; Jonathan Steinfeld
Journal:  J Allergy Clin Immunol       Date:  2019-08-16       Impact factor: 10.793

2.  One year of mepolizumab. Efficacy and safety in real-life in Italy.

Authors:  Diego Bagnasco; Marco Caminati; Francesco Menzella; Manlio Milanese; Giovanni Rolla; Carlo Lombardi; Caterina Bucca; Enrico Heffler; Giovanni Paoletti; Elisa Testino; Andrea Manfredi; Cristiano Caruso; Giuseppe Guida; Gianenrico Senna; Marco Bonavia; Anna Maria Riccio; Giorgio Walter Canonica; Giovanni Passalacqua
Journal:  Pulm Pharmacol Ther       Date:  2019-08-29       Impact factor: 3.410

3.  Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.

Authors:  Parameswaran Nair; Sally Wenzel; Klaus F Rabe; Arnaud Bourdin; Njira L Lugogo; Piotr Kuna; Peter Barker; Stephanie Sproule; Sandhia Ponnarambil; Mitchell Goldman
Journal:  N Engl J Med       Date:  2017-05-22       Impact factor: 91.245

4.  EAACI Biologicals Guidelines-Recommendations for severe asthma.

Authors:  Ioana Agache; Cezmi A Akdis; Mubeccel Akdis; Giorgio Walter Canonica; Thomas Casale; Tomas Chivato; Jonathan Corren; Derek K Chu; Stefano Del Giacco; Thomas Eiwegger; Breda Flood; Davide Firinu; James E Gern; Eckard Hamelmann; Nicola Hanania; Irene Hernández-Martín; Rebeca Knibb; Mika Mäkelä; Parameswaran Nair; Liam O'Mahony; Nikolaos G Papadopoulos; Alberto Papi; Hae-Sim Park; Luis Pérez de Llano; Oliver Pfaar; Santiago Quirce; Joaquin Sastre; Mohamed Shamji; Jurgen Schwarze; Oscar Palomares; Marek Jutel
Journal:  Allergy       Date:  2020-08-10       Impact factor: 13.146

Review 5.  Adherence to medication in children and adolescents with asthma: methods for monitoring and intervention.

Authors:  Christina Joanne Pearce; Louise Fleming
Journal:  Expert Rev Clin Immunol       Date:  2018-10-15       Impact factor: 4.473

6.  Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody.

Authors:  Philip E Silkoff; Francisco A Romero; Niroo Gupta; Robert G Townley; Henry Milgrom
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

7.  Negative affect, medication adherence, and asthma control in children.

Authors:  Bruce Bender; Lening Zhang
Journal:  J Allergy Clin Immunol       Date:  2008-07-07       Impact factor: 10.793

Review 8.  Mechanisms of Dupilumab.

Authors:  Hani Harb; Talal A Chatila
Journal:  Clin Exp Allergy       Date:  2019-09-30       Impact factor: 5.018

9.  Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children.

Authors:  Anja Jochmann; Luca Artusio; Angela Jamalzadeh; Prasad Nagakumar; Edgar Delgado-Eckert; Sejal Saglani; Andrew Bush; Urs Frey; Louise J Fleming
Journal:  Eur Respir J       Date:  2017-12-21       Impact factor: 16.671

10.  The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts.

Authors:  Louise Fleming; Clare Murray; Aruna T Bansal; Simone Hashimoto; Hans Bisgaard; Andrew Bush; Urs Frey; Gunilla Hedlin; Florian Singer; Wim M van Aalderen; Nadja H Vissing; Zaraquiza Zolkipli; Anna Selby; Stephen Fowler; Dominick Shaw; Kian Fan Chung; Ana R Sousa; Scott Wagers; Julie Corfield; Ioannis Pandis; Anthony Rowe; Elena Formaggio; Peter J Sterk; Graham Roberts
Journal:  Eur Respir J       Date:  2015-09-24       Impact factor: 16.671

View more
  4 in total

Review 1.  Severe Pediatric Asthma Therapy: Mepolizumab.

Authors:  Nicola Ullmann; Francesca Peri; Olivia Florio; Federica Porcaro; Elisa Profeti; Alessandro Onofri; Renato Cutrera
Journal:  Front Pediatr       Date:  2022-07-01       Impact factor: 3.569

2.  Association of mold levels in urban children's homes with difficult-to-control asthma.

Authors:  Stephen Vesper; Larry Wymer; John Kroner; Jacqueline A Pongracic; Edward M Zoratti; Frédéric F Little; Robert A Wood; Carolyn M Kercsmar; Rebecca S Gruchalla; Michelle A Gill; Meyer Kattan; Stephen J Teach; Shilpa Patel; Christine C Johnson; Leonard B Bacharier; James E Gern; Daniel J Jackson; Steven M Sigelman; Alkis Togias; Andrew H Liu; William W Busse; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2021-10-02       Impact factor: 14.290

Review 3.  Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma.

Authors:  Francesca Santamaria; Carla Ziello; Paola Lorello; Cristina Bouchè; Melissa Borrelli
Journal:  Front Pediatr       Date:  2022-07-19       Impact factor: 3.569

4.  Respiratory Symptoms, Allergies, and Environmental Exposures in Children with and without Asthma.

Authors:  Agata Wypych-Ślusarska; Martina Grot; Maria Kujawińska; Maciej Nigowski; Karolina Krupa-Kotara; Klaudia Oleksiuk; Joanna Głogowska-Ligus; Mateusz Grajek
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.